Developing treatments for radiation exposure effects
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support
This study is working on new treatments to help people who have been exposed to radiation, especially in emergencies, so they can feel better and recover more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11203144 on NIH RePORTER |
What this research studies
This research focuses on creating medical countermeasures to help mitigate or treat the effects of acute radiation exposure and internal contamination from radioactive materials. It involves collaboration with various institutions, including industry and academia, to advance these treatments through the necessary regulatory pathways for approval and licensure. Patients may benefit from new therapies designed to address the serious health impacts of radiation exposure, particularly in emergency situations. The research will also support bio dosimetry efforts to better understand radiation effects on the body.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been exposed to radiation or are at risk of such exposure, particularly in emergency or occupational settings.
Not a fit: Patients who have not been exposed to radiation or are not at risk of radiation exposure may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for individuals affected by radiation exposure, improving survival and recovery outcomes.
How similar studies have performed: Previous research in developing medical countermeasures for radiation exposure has shown promise, indicating that this approach is building on established findings.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Chang, Polly Yee — Sri International
- Study coordinator: Chang, Polly Yee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.